Volume 23, Number 4—April 2017
Research
Influence of Referral Pathway on Ebola Virus Disease Case-Fatality Rate and Effect of Survival Selection Bias
Table
Variable | Cohort 1, n = 48 | Cohort 2, n = 78 | p value |
---|---|---|---|
Case-fatality rate, % | 46 | 67 | 0.02 |
Age, median, IQR | 29 (14–40) | 34 (20–45) | 0.2 |
Children <15 years of age, no. (%) | 12 (44) | 15 (56) | 0.4 |
Days from symptom onset to EVD testing (IQR) | 4 (2–5) | 4 (3–6) | 0.7 |
Days from symptom onset to admission at ETC, median (IQR) | 6 (4–7) | 4 (2–5) | <0.001 |
Ct, median (IQR)† | 23 (21–26) | 20 (18–23) | <0.001 |
*Cohort 1 consisted of patients admitted directly to the ETC (Ebola treatment center) with confirmed EVD (Ebola virus disease); cohort 2 consisted of patients admitted directly to the ETC, where they were subsequently diagnosed with EVD. Ct, cycle threshold; IQR, interquartile range.
†Obtained from first blood sample drawn.
Page created: March 16, 2017
Page updated: March 16, 2017
Page reviewed: March 16, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.